NL8300727A - Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten. - Google Patents

Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten. Download PDF

Info

Publication number
NL8300727A
NL8300727A NL8300727A NL8300727A NL8300727A NL 8300727 A NL8300727 A NL 8300727A NL 8300727 A NL8300727 A NL 8300727A NL 8300727 A NL8300727 A NL 8300727A NL 8300727 A NL8300727 A NL 8300727A
Authority
NL
Netherlands
Prior art keywords
sulfuric acid
acid reaction
reaction
cells
color
Prior art date
Application number
NL8300727A
Other languages
English (en)
Dutch (nl)
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of NL8300727A publication Critical patent/NL8300727A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL8300727A 1982-02-26 1983-02-25 Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten. NL8300727A (nl)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2899382 1982-02-26
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP2899282 1982-02-26
JP8767582 1982-05-24
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP8767482 1982-05-24
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤
JP10804682 1982-06-23

Publications (1)

Publication Number Publication Date
NL8300727A true NL8300727A (nl) 1983-09-16

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8300727A NL8300727A (nl) 1982-02-26 1983-02-25 Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten.

Country Status (17)

Country Link
US (1) US4481137A (fr)
BE (1) BE896027A (fr)
BR (1) BR8300933A (fr)
DD (1) DD209634A5 (fr)
DE (1) DE3306297A1 (fr)
DK (1) DK93383A (fr)
FI (1) FI830638L (fr)
FR (1) FR2522267A1 (fr)
GB (1) GB2117385B (fr)
GR (1) GR78097B (fr)
LU (1) LU84662A1 (fr)
NL (1) NL8300727A (fr)
NO (1) NO830669L (fr)
PL (1) PL240784A1 (fr)
PT (1) PT76296B (fr)
RO (1) RO85901B (fr)
SE (1) SE8301073L (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインｉｉｉとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
WO1990000400A1 (fr) * 1988-07-15 1990-01-25 The Trustees Of Columbia University In The City Of New York Facteurs ameliorateurs de necrose tumorale et procedes de preparation et d'utilisation de tels facteurs
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5641867A (en) 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
AU734766B2 (en) * 1997-03-14 2001-06-21 Atlas Pharmaceuticals Inc. Agent for preventing and/or treating cachexia
RU2136695C1 (ru) * 1998-03-18 1999-09-10 ЗАОПП "Эндо-Фарм-А" Сывороточный гликопротеин, обладающий биологической активностью в сверхмалых дозах
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
ES2661168T3 (es) 2003-07-12 2018-03-27 Accelerate Diagnostics, Inc. Biodetección sensible y rápida
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
WO2012122314A2 (fr) 2011-03-07 2012-09-13 Accelr8 Technology Corporation Systèmes de purification rapide de cellules
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
BE896027A (fr) 1983-08-25
DE3306297A1 (de) 1983-09-15
DD209634A5 (de) 1984-05-16
FI830638A7 (fi) 1983-08-27
PL240784A1 (en) 1983-11-07
GR78097B (fr) 1984-09-26
FI830638A0 (fi) 1983-02-25
DK93383D0 (da) 1983-02-25
NO830669L (no) 1983-08-29
US4481137A (en) 1984-11-06
GB2117385A (en) 1983-10-12
FI830638L (fi) 1983-08-27
SE8301073D0 (sv) 1983-02-25
LU84662A1 (fr) 1983-09-08
PT76296A (en) 1983-03-01
GB2117385B (en) 1985-05-09
RO85901A (fr) 1985-01-24
DK93383A (da) 1983-08-27
SE8301073L (sv) 1983-08-27
BR8300933A (pt) 1983-11-16
GB8305330D0 (en) 1983-03-30
FR2522267A1 (fr) 1983-09-02
RO85901B (ro) 1985-01-30
PT76296B (en) 1985-11-12

Similar Documents

Publication Publication Date Title
NL8300727A (nl) Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten.
DK169479B1 (da) Fremgangsmåde til fremstilling af humanspecifikt type II-interferon
CN114984032A (zh) Dna四面体框架核酸-绿原酸复合物及其在制备治疗肝纤维化的药物中的用途
WO1999051720A2 (fr) Procedes de production de cytokines therapeutiques
Paronetto Immunologic factors in alcoholic liver disease
CN101167755B (zh) 具有抗肿瘤活性的蜈蚣多糖蛋白复合物的制备方法及用途
WO2022183539A1 (fr) Composition pharmaceutique destinée au traitement du sepsis, et utilisation associée
CN118356409A (zh) 一种肿瘤靶向的仿生混合囊泡的制备方法及应用
JPS6011890B2 (ja) ツモアネクロシスフアクタ−の製造方法
KR20190093500A (ko) Cd56+ 자연살해세포를 포함하는 항암용 조성물
CN103027924B (zh) 拟康氏木霉胞外多糖作为治疗胃癌药物的应用
CN119280412B (zh) 触发细胞外囊泡级联渗透的工程化细胞膜囊泡及其构建方法和应用
JPS6245208B2 (fr)
CN100406058C (zh) 一种胎盘因子及其制备方法与应用
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JPS58203918A (ja) 糖蛋白質およびその製造法ならびに腫瘍治療剤
FI77157B (fi) Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.
US20020155097A1 (en) Antitumor and antiviral medications and method for producing the same
JPS58203917A (ja) 糖蛋白質およびその製法ならびに腫瘍治療剤
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JPS58225024A (ja) 糖蛋白質およびその製造方法ならびに腫瘍治療剤
KR870001433B1 (ko) 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법
JPH0446928B2 (fr)
RU2134581C1 (ru) Средство для лечения облученных млекопитающих
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed